BPiDI: A novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse

British Journal of Pharmacology

Volumn 163, Issue 2, 2011, Pages 346-357

  Wooters, Thomas E ^a,e   Smith, Andrew M ^b   Pivavarchyk, Marharyta ^b   Siripurapu, Kiran B ^b   McIntosh, J Michael ^c   Zhang, Zhenfa ^b,d   Crooks, Peter A ^b   Bardo, Michael T ^a   Dwoskin, Linda P ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

6 2; dopamine; nicotine; nicotinic receptor antagonist; rat; self administration; tobacco smoking

Indexed keywords

ALPHA CONOTOXIN MII; DOPAMINE; N,N' DECANE 1,10 DIYL BIS 3 PICOLINIUM DIIODIDE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; TRITIUM; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CIGARETTE SMOKING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG STRUCTURE; FOOD INTAKE; INHIBITION KINETICS; LETHARGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; TOBACCO DEPENDENCE; WEIGHT REDUCTION;

ALLOSTERIC REGULATION; ANIMALS; CONOTOXINS; CORPUS STRIATUM; DOPAMINE; DRUG TOLERANCE; MALE; NICOTINE; NICOTINIC ANTAGONISTS; PICOLINES; PYRIDINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SELF ADMINISTRATION; TOBACCO USE DISORDER;

EID: 79955044535     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01220.x     Document Type: Article

References (67)

1. Agneter E, Singer EA, Sauermann W, Feuerstein TJ, (1997). The slope parameter of concentration-response curves used as a touchstone for the existence of spare receptors. Naunyn Schmiedeberg's Arch Pharmacol 356: 283-292. (Pubitemid 27376457)
2. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
3. Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA, (2002). bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors. Bioorg Med Chem Lett 12: 3067-3071.
4. 3H]dopamine release from rat striatal synaptosomes. J Pharmacol Exp Ther 312: 231-237. (Pubitemid 40096473)
5. Brunzell DH, Boschen KE, Hendrick ES, Beardsley PM, McIntosh JM, (2009). Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive-ratio responding maintained by nicotine. Neuropsychopharmacology 35: 665-673.
6. Caillé S, Guillem K, Cador M, Manzoni O, Georges F, (2009). Voluntary nicotine consumption triggers in vivo potentiation of cortical excitatory drives to midbrain dopaminergic neurons. J Neurosci 29: 10410-10415.
7. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM, (1996). A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271: 7522-7528. (Pubitemid 26107027)
8. Champtiaux N, Han ZY, Bessis A, Rossi FM, Zoli M, Marubio L, et al,. (2002). Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 22: 1208-1217. (Pubitemid 34163722)
9. Corrigall WA, Herling S, Coen KM, (1988). Evidence for opioid mechanisms in the behavioral effects of nicotine. Psychopharmacology (Berl) 96: 29-35.
10. Corrigall WA, Franklin KB, Coen KM, Clarke PB, (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107: 285-289.
11. Corrigall WA, Coen KM, Adamson KL, (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653: 278-284. (Pubitemid 24252850)
12. Corringer PJ, Sallette J, Changeux JP, (2006). Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity? J Physiol 99: 162-171.
13. Dani JA, Heinemann S, (1996). Molecular and cellular aspects of nicotine abuse. Neuron 16: 905-908. (Pubitemid 26171196)
14. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al,. (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl. 1): 227-241. (Pubitemid 39298267)
15. Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM, et al,. (2008). In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron 60: 123-136.
16. Dwoskin LP, Bardo MT, (2009). Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse. Neuropsychopharmacology 34: 244-246.
17. Dwoskin LP, Wooters TE, Sumithran SP, Siripurapu KB, Joyce BM, Lockman PR, et al,. (2008). N,N′-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. J Pharmacol Exp Ther 326: 563-576.
18. Exley R, Clements MA, Hartung H, McIntosh JM, Cragg SJ, (2008). Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33: 2158-2166. (Pubitemid 351992087)
19. Giniatullin R, Nistri A, Yakel JL, (2005). Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci 28: 371-378. (Pubitemid 40853860)
20. Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, et al,. (2005). Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. Mol Pharmacol 67: 2007-2015. (Pubitemid 41007782)
21. Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, et al,. (2007). The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 74: 1235-1246. (Pubitemid 47417935)
22. Grilli M, Parodi M, Raiteri M, Marchi M, (2005). Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release. J Neurochem 93: 1353-1360. (Pubitemid 40776588)
23. 3H] dopamine overflow from superfused rat striatal slices. J Pharmacol Exp Ther 306: 1011-1020. (Pubitemid 37025308)
24. Harkness PC, Millar NS, (2002). Changes in conformation and subcellular distribution of α4β2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J Neurosci 22: 10172-10181. (Pubitemid 35416856)
25. Ikemoto S, Qin M, Liu ZH, (2006). Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area. J Neurosci 26: 723-730. (Pubitemid 43237066)
26. Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, D.C.
27. Janson AM, Meana JJ, Goiny M, Herrera-Marschitz M, (1991). Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis study. Neurosci Lett 134: 88-92.
28. Kenakin TP, (1992). Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions. Mol Pharmacol 41: 699-707. (Pubitemid 23021459)
29. King SL, Caldarone BJ, Picciotto MR, (2004). Beta2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration. Neuropharmacology 47 (Suppl. 1): 132-139. (Pubitemid 39298259)
30. Koob GF, Volkow ND, (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
31. Kulak JM, Nguyen TA, Olivera BM, McIntosh JM, (1997). Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 17: 5263-5270. (Pubitemid 127777368)
32. Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, et al,. (2009). Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS 11: 167-177.
33. Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M, Wells C, et al,. (2010). Sazetidine-A, a selective {alpha}4{beta2} nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther 332: 933-939.
34. Lopez-Hernandez GY, Sanchez-Padilla J, Ortiz-Acevedo A, Lizardi-Ortiz J, Salas-Vincenty J, Rojas LV, et al,. (2004). Nicotine-induced up-regulation and desensitization of alpha4beta2 neuronal nicotinic receptors depend on subunit ratio. J Biol Chem 279: 38007-38015. (Pubitemid 39195516)
35. 125I]- epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 46: 1141-1157. (Pubitemid 38529938)
36. McCallum SE, Collins AC, Paylor R, Marks MJ, (2006). Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl) 184: 314-327. (Pubitemid 43255848)
37. Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, et al,. (2003). Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17: 1329-1337. (Pubitemid 36560833)
38. 125I]α-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience 137: 565-572. (Pubitemid 43031522)
39. Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J, (2003). Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 63: 332-341. (Pubitemid 36158368)
40. Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT, (2006). Effects of a novel nicotinic receptor antagonist, N,N′-dodecane-1,12-diyl-bis-3- picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Psychopharmacology (Berl) 184: 426-434. (Pubitemid 43255859)
41. O'Connor EC, Parker D, Rollema H, Mead AN, (2010). The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology (Berl) 208: 365-376.
42. Parker SL, Fu Y, McAllen K, Luo J, McIntosh JM, Lindstrom JM, et al,. (2004). Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the alpha6 subunit. Mol Pharmacol 65: 611-622. (Pubitemid 38264028)
43. Perez XA, Bordia T, McIntosh JM, Grady SR, Quik M, (2008). Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function. Mol Pharmacol 74: 844-853.
44. Perez XA, O'Leary KT, Parameswaran N, McIntosh JM, Quik M, (2009). Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment. Mol Pharmacol 75: 938-946.
45. Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, Kellar KJ, (2007). Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322: 306-315. (Pubitemid 46956379)
46. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al,. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177. (Pubitemid 28092475)
47. Picciotto MR, Addy NA, Mineur YS, Brunzell DH, (2008). It is not 'either/or': activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84: 329-342.
48. Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, et al,. (2008). Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327.
49. Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT, (2007). The effects of a novel nicotinic receptor antagonist N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology 52: 755-763. (Pubitemid 46227466)
50. Rauhut AS, Neugebauer NM, Dwoskin LP, Bardo MT, (2003). Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berl) 169: 1-9. (Pubitemid 37088608)
51. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, et al,. (2005). Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46: 595-607.
52. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, et al,. (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65: 1526-1535. (Pubitemid 38668310)
53. Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR, (2007). Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol Pharmacol 71: 1563-1571. (Pubitemid 47010909)
54. Smith AM, Pivavarchyk M, Wooters TE, Zhang Z, Zheng G, McIntosh JM, et al,. (2010). Repeated nicotine administration robustly increases bPiDDB inhibitory potency at α6β2* nicotinic receptors that mediate nicotine-evoked dopamine release. Biochem Pharmacol 80: 402-409.
55. Stairs DJ, Neugebauer NM, Bardo MT, (2010). Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats. Behav Pharmacol 21: 182-193.
56. Stephenson RP, (1956). A modification of receptor theory. Br J Pharmacol Chemother 11: 379-393.
57. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et al,. (2004). Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306: 1029-1032. (Pubitemid 39482905)
58. Tapper AR, McKinney SL, Marks MJ, Lester HA, (2007). Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiol Genomics 31: 422-428. (Pubitemid 350127782)
59. 3H]dopamine uptake. J Pharmacol Exp Ther 280: 1432-1444. (Pubitemid 27166742)
60. Visanji NP, Mitchell SN, O'Neill MJ, Duty S, (2006). Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat. Neuropharmacology 50: 36-46. (Pubitemid 43069770)
61. Watkins SS, Epping-Jordan MP, Koob GF, Markou A, (1999). Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62: 743-751. (Pubitemid 29127180)
62. Wenger BW, Bryant DL, Boyd RT, McKay DB, (1997). Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35. J Pharmacol Exp Ther 281: 905-913. (Pubitemid 27203826)
63. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol 57: 913-925. (Pubitemid 30253374)
64. Yang KC, Jin GZ, Wu J, (2009). Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology. Acta Pharmacol Sin 30: 740-751.
65. Yoshimura RF, Hogenkamp DJ, Li WY, Tran MB, Belluzzi JD, Whittemore ER, et al,. (2007). Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats. J Pharmacol Exp Ther 323: 907-915. (Pubitemid 350146068)
66. Zhu BT, (1993). The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors. J Pharmacol Toxicol Methods 29: 85-91.
67. Zumstein A, Karduck W, Starke K, (1981). Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol 316: 205-217. (Pubitemid 11078345)